8 research outputs found
ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice
Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.Peer reviewe
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy" AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sante) \nPOLLAR (Impact of Air POLLution on Asthma and Rhinitis)\nGARD Demonstration project
Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.Peer reviewe
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
Background In all societies, the burden and cost of allergic and chronic
respiratory diseases are increasing rapidly. Most economies are
struggling to deliver modern health care effectively. There is a need to
support the transformation of the health care system into integrated
care with organizational health literacy. Main body As an example for
chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new
project of the ARIA (Allergic Rhinitis and its Impact on Asthma)
initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis,
EIT Health), in collaboration with professional and patient
organizations in the field of allergy and airway diseases, are proposing
real-life ICPs centred around the patient with rhinitis, and using
mHealth to monitor environmental exposure. Three aspects of care
pathways are being developed: (i) Patient participation, health literacy
and self-care through technology-assisted “patient activation”, (ii)
Implementation of care pathways by pharmacists and (iii) Next-generation
guidelines assessing the recommendations of GRADE guidelines in rhinitis
and asthma using real-world evidence (RWE) obtained through mobile
technology. The EU and global political agendas are of great importance
in supporting the digital transformation of health and care, and MASK
has been recognized by DG Sante as a Good Practice in the field of
digitally-enabled, integrated, person-centred care. Conclusion In 20
years, ARIA has considerably evolved from the first multimorbidity
guideline in respiratory diseases to the digital transformation of
health and care with a strong political involvement
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
Digital anamorphosis is used to define a distorted image of health and
care that may be viewed correctly using digital tools and strategies.
MASK digital anamorphosis represents the process used by MASK to develop
the digital transformation of health and care in rhinitis. It
strengthens the ARIA change management strategy in the prevention and
management of airway disease. The MASK strategy is based on validated
digital tools. Using the MASK digital tool and the CARAT online enhanced
clinical framework, solutions for practical steps of digital enhancement
of care are proposed
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study
Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12 143 users were registered. A total of 6 949 users reported at least one VAS data recording. Among them, 1 887 users reported ≥7 VAS data. About 1 195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR ≥70% and PDC ≤1.25), 51 (4.23%) were partly adherent (MPR ≥70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting